Cord Blood America gains new customers with NeoCells acquisition
This article was originally published in Clinica
Executive Summary
Stem cell preservation specialist Cord Blood America has bulked up its sample bank by acquiring ed the assets of NeoCells, a stem cell storage company and subsidiary of ViviCells International, for $320,000. The deal gives Cord Blood an extra 2,700 customers this year, and fits with the company's strategy to grow its gross margins by acquiring more patient samples.